COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,678 Articles (22,913 medRxiv, 8,765 bioRxiv)

Most recent first Previous |  Page 950: Articles 9491-9500  | Next

Presence of Symptoms 6 Weeks After COVID-19 Among Vaccinated and Unvaccinated U.S. Healthcare Personnel
Mohr, N. M., Plumb, I. D., Harland, K. K., Pilishvili, T., Flemming-Dutra, K. E., Krishnadasan, A., Hoth, K. F., Saydah, S. H., Mankoff, Z., Haran, J. P., Briggs-Hagen, M., Santos Leon, E., Talan, D. A., Project PREVENT Network
10.1101/2022.02.16.22271092 — Posted: 2022-02-25
Psychosocial factors associated with mental health and quality of life during the COVID-19 pandemic among low-income urban dwellers in Peninsular Malaysia
Min Fui, W., Abdul Majid, H., Ismail, R., Su, T. T., Maw Pin, T., Said, M. A.
10.1101/2022.02.21.22271310 — Posted: 2022-02-25
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
Kawasuji, H., Morinaga, Y., Tani, H., Saga, Y., Kaneda, M., Murai, Y., Ueno, A., Miyajima, Y., Fukui, Y., Nagaoka, K., Ono, C., Matsuura, Y., Niimi, H., Yamamoto, Y.
10.1101/2022.02.23.22271433 — Posted: 2022-02-25
Detection of SARS-CoV-2 in air and on surfaces in rooms of infected nursing home residents
Linde, K. J., Wouters, I. M., Kluytmans, J. J. A. J. W., Kluytmans, M. F. Q., Pas, S. D., GeurtsvanKessel, C. H., Koopmans, M. P. G., Meier, M., Meijer, P., Raben, C. R., Spithoven, J., Tersteeg, M. H. G., Heederik, D. J. J., Dohmen, W.
10.1101/2022.02.16.22271053 — Posted: 2022-02-25
The impact of COVID passport mandates on the number of cases of and hospitalizations with COVID-19 in the UK: a difference-in-differences analysis
Lopez-Güell, K., Prats-Uribe, A., Catala, M., Prats, C., Hein, J., PRIETO-ALHAMBRA, D.
10.1101/2022.02.24.22271325 — Posted: 2022-02-25
Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2
Smid, M., Berec, L., Majek, O., Pavlik, T., Jarkovsky, J., Pribylova, L., Weiner, J., Barusova, T., Trnka, J.
10.1101/2022.02.24.22271396 — Posted: 2022-02-25
CoviVac vaccination induces production of neutralizing antibodies against Delta and Omicron variants of SARS-CoV-2
Kozlovskaya, L. I., Gordeychuk, I., Piniaeva, A., Kovpak, A., Shishova, A., Lunin, A., Shustova, E., Apolokhov, V., Fominykh, K., Ivin, Y., Kondrashova, A., Volok, V., Tcelykh, I., Siniugina, A., Ishmukhametov, A. A.
10.1101/2022.02.10.22270781 — Posted: 2022-02-25
Mitoquinone mesylate targets SARS-CoV-2 and associated lung inflammation through host pathways
Petcherski, A., Sharma, M., Daskou, M., Satta, S., Vasilopoulos, H., Hugo, C., Ritou, E., Dillon, B. J., Fung, E., Garcia, G., Scafoglio, C., Purkayastha, A., Gomperts, B., Fishbein, G. A., Arumugaswami, V., Liesa, M., Shirihai, O. S., Kelesidis, T.
10.1101/2022.02.22.481100 — Posted: 2022-02-25
When mistrust in the government and scientists reinforce social inequalities in vaccination against Covid-19
Bajos, N., Spire, A., Silberzan, L., Sireyjol, A., Jusot, F., Meyer, L., Franck, J.-E., Warszawski, J.
10.1101/2022.02.23.22271397 — Posted: 2022-02-24
Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination
Batra, G., Murugesan, D. R., Das, S. J., Chattopadhyay, S., Mehdi, F., Ayushi, , Gosain, M., Singh, S., Deshpande, S., Bhattacharya, J., Pandey, A. K., Jha, S., Goswami, S., Das, A., Dwivedi, T., Sharma, N., Kumar, S., Sharma, P., Kapoor, S., Kshetrapal, P., Wadhwa, N., Thiruvengadam, R., Kumar, R., Gupta, R., Garg, P. K., Bhatnagar, S., DBT Consortium for COVID-19 Research
10.1101/2022.02.23.22271381 — Posted: 2022-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).